TOKENPOST
1 min read
Add as a preferred source on Google

Roche Q3 Sales Rise 8% in Swiss Francs as Pharma Beats Forecast

Group sales reached CHF 16.13 billion. Pharmaceuticals Division sales topped the consensus forecast by CHF 350 million.

By John Kim
Published
Amber medicine vials rise across a row of stone plinths / TokenPost.ai
Amber medicine vials rise across a row of stone plinths / TokenPost.ai

Roche’s third-quarter Group sales rose 8% in Swiss francs from a year earlier to CHF 16.13 billion, topping the CHF 15.752 billion consensus estimate. At constant exchange rates, sales growth was 7%.

The Pharmaceuticals Division recorded CHF 12.583 billion in sales for the quarter, CHF 350 million above its CHF 12.233 billion consensus forecast.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…